Delivery Order SPE2DB25D3504-SPE2DB25FVVMQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,648.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a completion date of August 6, 2025. This competitive award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.22 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays, with an ultimate completion date of September 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.39 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 13, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $6,756.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal spray, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,673.49 on August 13, 2025, for the supply of Valtoco 10 mg nasal sprays. This is a firm fixed price contract with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The contract is set to reach...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,259.24 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of September 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,183.28 for Valtoco 15 mg nasal sprays on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $2,403.19 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. The contract, which is not set-aside, was competitively awarded on August 29, 2025, with an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order operates under firm fixed-price terms and represents a child contract to...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVVMQDelivery Order
The Defense Logistics Agency awarded a $2,285.52 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with a firm fixed price structure and an ultimate completion date of July 15, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. Valtoco (diazepam nasal spray) is an acute seizure treatment used in emergency medical settings, making this delivery order consistent with AmerisourceBergen's established role as a critical vendor supplying specialized pharmaceuticals to military and veteran healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains extensive federal procurement experience through competitively awarded contracts with DLA and the Defense Health Agency, delivering a comprehensive range of medications and medical supplies across therapeutic domains to support global military healthcare programs and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/14/25 |